Sleep Deprivation : Effects on Driving Performance and Central Fatigue
NCT ID: NCT01606020
Last Updated: 2012-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2011-09-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Sleep Deprivation on Physiological and Perceptual Responses During Exercise
NCT05313932
Effect of Sleep Extension in Prevention to Sleep Deprivation
NCT06928168
Effects of Sleep Deprivation on Diaphragm Command During an Inspiratory Endurance Trial in Healthy Volunteers.
NCT02725190
Benefits of Sleep Extension on Performances During Total Sleep Deprivation (BankingSleep)
NCT02352272
Effect of Total Sleep Deprivation on Vascular Function
NCT04535219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep deprivation First
First night D7 :
Overnight, the subjects stay in their homes (reading, watching TV, playing cards). Two experimenters will take turns to never leave them alone and avoid any micro-sleep.
Second night D28 :
Overnight, the subjects stay in their homes. No intervention during this night.
sleep deprivation
Overnight, the subjects stay in their homes (reading, watching TV, playing cards). Two experimenters will take turns to never leave them alone and avoid any micro-sleep.
No intervention
Overnight, the subjects stay in their homes. No intervention during this night
sleep deprivation second
First night D7 :
Overnight, the subjects stay in their homes. No intervention during this night.
Second night D28 :
Overnight, the subjects stay in their homes (reading, watching TV, playing cards). Two experimenters will take turns to never leave them alone and avoid any micro-sleep.
sleep deprivation
Overnight, the subjects stay in their homes (reading, watching TV, playing cards). Two experimenters will take turns to never leave them alone and avoid any micro-sleep.
No intervention
Overnight, the subjects stay in their homes. No intervention during this night
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleep deprivation
Overnight, the subjects stay in their homes (reading, watching TV, playing cards). Two experimenters will take turns to never leave them alone and avoid any micro-sleep.
No intervention
Overnight, the subjects stay in their homes. No intervention during this night
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular physical activity
Exclusion Criteria
* carrying a cardiac pacemaker
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume MILLET, PhD
Role: STUDY_CHAIR
Jean Monnet University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00895-36
Identifier Type: OTHER
Identifier Source: secondary_id
1108128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.